Clinical and molecular characterization of novel FARS2 variants causing neonatal mitochondrial disease.
FARS2
Functional assays
Mitochondrial disease
Mitochondrial phenylalanyl-tRNA synthetase
Variant classification
Journal
Molecular genetics and metabolism
ISSN: 1096-7206
Titre abrégé: Mol Genet Metab
Pays: United States
ID NLM: 9805456
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
14
06
2023
revised:
22
07
2023
accepted:
22
07
2023
medline:
14
11
2023
pubmed:
1
8
2023
entrez:
31
7
2023
Statut:
ppublish
Résumé
FARS2 encodes the mitochondrial phenylalanyl-tRNA synthetase (mtPheRS), which is essential for charging mitochondrial (mt-) tRNA
Identifiants
pubmed: 37523899
pii: S1096-7192(23)00287-1
doi: 10.1016/j.ymgme.2023.107657
pii:
doi:
Substances chimiques
FARS2 protein, human
EC 6.1.1.20
Mitochondrial Proteins
0
Phenylalanine-tRNA Ligase
EC 6.1.1.20
RNA, Transfer
9014-25-9
RNA, Transfer, Phe
0
Types de publication
Case Reports
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
107657Subventions
Organisme : NIGMS NIH HHS
ID : R01 GM125908
Pays : United States
Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors have no conflicts of interest to disclose.